메쥬

0088M0KOSDAQ

53.3 / 100

Reference Date: 2026-09-08

Financial Score16.5 / 40

News Sentiment20.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly up 2.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Meju is a medical device company specializing in the development and manufacturing of ambulatory remote patient monitoring (aRPM) systems and wearable patch-based vital sign monitoring devices. The company provides central monitoring systems, ECG monitors, and smart patches to manage patient health in real-time, both in hospitals and remotely, while adhering to international standards such as IEC 60601 and ISO 13485 to ensure product safety and quality.

Number of Employees

64people

Average Salary

50.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

31.40Industry Average 15.000.0Point

2.1x industry avg (risky)

PBR

13.10Industry Average 1.200.0Point

10.9x industry avg (risky)

ROE

—Industry Average 8.003.5Point

Debt Ratio

6.18Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 5.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

2.0 / 4

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 83

Positive
송재훈의 바이오 투자 통했다…민트벤처파트너스, 3곳 코스닥 입성
송재훈 회장의 민트벤처파트너스가 메쥬를 포함한 바이오 기업들의 코스닥 상장 성공으로 인해 투자 성과가 크게 향상되었다.
Positive
발 묶인 이동로봇·쓰레기 취급 폐배터리…규제자유특구서 성장동력 ...
규제자유특구 내에서 메쥬의 이동로봇 및 폐배터리 관련 실증 성공이 표준화되어 기업 성장 동력으로 작용할 것으로 기대됩니다.
Positive
'로봇은 움직이며 작업 못해' 낡은 규제 정비해 로봇산업 날개
로봇산업 규제 완화로 메쥬를 포함한 관련 기업들의 기술 실증 및 사업화 속도가 가속화되어 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 13,250Won52-week high 51,30052-week low 10,610

1-month return4.0Point

1m +2.87% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13